Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuhisa Misawa is active.

Publication


Featured researches published by Kazuhisa Misawa.


Emerging Infectious Diseases | 2014

Mother-to-Child Transmission of Congenital Chagas Disease, Japan

Kazuo Imai; Takuya Maeda; Yusuke Sayama; Kei Mikita; Yuji Fujikura; Kazuhisa Misawa; Morichika Nagumo; Osamu Iwata; Takeshi Ono; Ichiro Kurane; Yasushi Miyahira; Akihiko Kawana; Sachio Miura

We report a patient with congenital Chagas disease in Japan. This report reemphasizes the role of neglected and emerging tropical diseases in the era of globalization. It also indicates the need for increased vigilance for detecting Chagas disease in non–disease-endemic countries.


BMC Infectious Diseases | 2017

A novel diagnostic method for malaria using loop-mediated isothermal amplification (LAMP) and MinION™ nanopore sequencer

Kazuo Imai; Norihito Tarumoto; Kazuhisa Misawa; Jun Sakai; Kyoko Hayashida; Yuki Eshita; Ryuichiro Maeda; Josef Tuda; Takashi Murakami; Shigefumi Maesaki; Yutaka Suzuki; Junya Yamagishi; Takuya Maeda

BackgroundA simple and accurate molecular diagnostic method for malaria is urgently needed due to the limitations of conventional microscopic examination. In this study, we demonstrate a new diagnostic procedure for human malaria using loop mediated isothermal amplification (LAMP) and the MinION™ nanopore sequencer.MethodsWe generated specific LAMP primers targeting the 18S–rRNA gene of all five human Plasmodium species including two P. ovale subspecies (P. falciparum, P. vivax, P. ovale wallikeri, P. ovale curtisi, P. knowlesi and P. malariae) and examined human blood samples collected from 63 malaria patients in Indonesia. Additionally, we performed amplicon sequencing of our LAMP products using MinION™ nanopore sequencer to identify each Plasmodium species.ResultsOur LAMP method allowed amplification of all targeted 18S–rRNA genes of the reference plasmids with detection limits of 10–100 copies per reaction. Among the 63 clinical samples, 54 and 55 samples were positive by nested PCR and our LAMP method, respectively. Identification of the Plasmodium species by LAMP amplicon sequencing analysis using the MinION™ was consistent with the reference plasmid sequences and the results of nested PCR.ConclusionsOur diagnostic method combined with LAMP and MinION™ could become a simple and accurate tool for the identification of human Plasmodium species, even in resource-limited situations.


Journal of Microbiological Methods | 2017

Development of a highly resolved loop-mediated isothermal amplification method to detect the N526K ftsI mutation of β-lactamase-negative ampicillin-resistant Haemophilus influenzae

Shinsuke Tamura; Takuya Maeda; Kazuhisa Misawa; Morichika Osa; Takaaki Hamamoto; Atsushi Yuki; Kazuo Imai; Kei Mikita; Kyoko Morichika; Akihiko Kawana; Hiroshi Matsumoto; Shigeaki Nonoyama

Rapid and easy detection of sequence polymorphisms, including nucleotide point mutations of bacterial pathogens responsible for amino acid substitutions linked to drug resistance, is essential for the proper use of antimicrobial agents. Here, a detection method using loop-mediated amplification (LAMP) combined with amplification refractory mutation system (ARMS) to accurately distinguish a different single nucleotide in the target sequence was established, named ARMS-SNP LAMP. This procedure is capable of species-specific detection of a nucleotide (1578T) in the ftsI gene on Haemophilus influenzae without amplifying the sequence carrying the point mutations (T1578G/A) in β-lactamase-negative ampicillin resistant (BLNAR) strains. Reactions were performed at 61°C for 45min. Successful target gene amplifications were detected by measuring real-time turbidity using a turbidimeter and visual detection. The assay had a detection limit of 10.0pg of genomic DNA per reaction and showed specificity against 52 types of pathogens, whereas amplifications were completely blocked in even 100.0ng/μL of genomic DNA with point mutations at T1578G and T1578A. The expected ARMS-SNP LAMP products were confirmed through identical melting curves in real-time LAMP procedures. This novel procedure was also used to analyze 57 clinical isolates of H. influenzae. All 25 clinical isolates with the naïve sequence of 1578T gave positive results. In addition, concordant negative results were obtained for 31 of the BLNAR strains with the T1578G mutation and one strain with the T1578A mutation. The ARMS-SNP LAMP method is a simple and rapid method for SNP-genotyping of a clinical isolate as point-of-care testing (POCT) technology. It is suitable for use in both resource-limited situations and well-equipped clinical settings because of its simplicity and convenience.


Journal of Microbiological Methods | 2017

A novel detection procedure for mutations in the 23S rRNA gene of Mycoplasma pneumoniae with peptide nucleic acid-mediated loop-mediated isothermal amplification assay

Jun Sakai; Takuya Maeda; Norihito Tarumoto; Kazuhisa Misawa; Shinsuke Tamura; Kazuo Imai; Toshiyuki Yamaguchi; Satoshi Iwata; Takashi Murakami; Shigefumi Maesaki

Rapid and easy detection of a single nucleotide point mutation of bacterial genes, which is directly linked to drug susceptibility, is essential for the proper use of antimicrobial agents. Here, we established a detection method using a peptide nucleic acid mediated loop-mediated amplification (LAMP) assay for macrolide (ML)-susceptible Mycoplasma pneumoniae. This assay specifically detected the absence of missense mutations encoding the central loop of domain V in the gene encoding 23S rRNA, which can reduce the affinity for MLs and subsequently generate ML-resistant strains of M. pneumoniae. Reactions were performed at 62°C for 60min and targeted gene amplifications were detected by real-time turbidity with a turbidimeter and naked-eye inspection of a color change. The assay had an equivalent detection limit of 100.0fg of DNA with the turbidimeter and showed specificity against 54 types of pathogens, whereas amplification was completely blocked, even at 100.0pg of DNA per reaction, in the presence of point mutations at 2063A and 2064A. The expected LAMP products were confirmed through identical melting curves in real-time LAMP procedures. This method would be a simple and rapid protocol for single nucleotide polymorphism genotyping as point-of-care testing technology without amplification of the sequences carrying the point mutations 2063A and 2064A in ML-resistant M. pneumoniae strains.


BMC Research Notes | 2018

Single nucleotide polymorphisms in genes encoding penicillin-binding proteins in β-lactamase-negative ampicillin-resistant Haemophilus influenzae in Japan

Kazuhisa Misawa; Norihito Tarumoto; Shinsuke Tamura; Morichika Osa; Takaaki Hamamoto; Atsushi Yuki; Yuji Kouzaki; Kazuo Imai; Runtuwene Lucky Ronald; Toshiyuki Yamaguchi; Takashi Murakami; Shigefumi Maesaki; Yutaka Suzuki; Akihiko Kawana; Takuya Maeda

Objectiveβ-Lactamase-negative ampicillin-resistant Haemophilus influenzae is a common opportunistic pathogen of hospital- and community-acquired infections, harboring multiple single nucleotide polymorphisms in the ftsI gene, which codes for penicillin-binding protein-3. The objectives of this study were to perform comprehensive genetic analyses of whole regions of the penicillin-binding proteins in H. influenzae and to identify additional single nucleotide polymorphisms related to antibiotic resistance, especially to ampicillin and other cephalosporins.ResultsIn this genome analysis of the ftsI gene in 27 strains of H. influenzae, 10 of 23 (43.5%) specimens of group III genotype β-lactamase-negative ampicillin-resistant H. influenzae were paradoxically classified as ampicillin-sensitive phenotypes. Unfortunately, we could not identify any novel mutations that were significantly associated with ampicillin minimum inhibitory concentrations in other regions of the penicillin-binding proteins, and we reconfirmed that susceptibility to β-lactam antibiotics was mainly defined by previously reported SNPs in the ftsI gene. We should also consider detailed changes in expression that lead to antibiotic resistance in the future because the acquisition of resistance to antimicrobials can be predicted by the expression levels of a small number of genes.


Journal of Infection and Chemotherapy | 2016

Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman's disease in an HIV-positive patient

Morichika Osa; Takuya Maeda; Kazuhisa Misawa; Kazuo Imai; Yuji Fujikura; Akihiko Kawana

We report a patient with HIV-associated multicentric Castlemans disease who had recurrent human herpesvirus-8 viremia associated with intermittent febrile exanthema and lymphadenopathy. Although the patient relapsed after single-agent treatment with liposomal doxorubicin, weekly infusions of rituximab led to complete remission even though the reactivation of the Kaposis sarcoma was unfortunately observed. Rituximab could not only eliminate the accumulation of HHV-8 load but also play a part in the modulation of dysregulated CD20-positive B cells in HIV-associated multicentric Castlemans disease.


Journal of Infection and Chemotherapy | 2016

Diagnosis of imported Ugandan typhoid fever based on local outbreak information: A case report

Shinichiro Ota; Yohei Maki; Kazuma Mori; Takaaki Hamamoto; Atsushi Kurokawa; Masashi Ishihara; Takayuki Yamamoto; Kazuo Imai; Kazuhisa Misawa; Atsushi Yuki; Yuji Fujikura; Takuya Maeda; Akihiko Kawana

Re-emerging multidrug-resistant typhoid fever is becoming a worldwide threat, especially in East Africa. At the beginning of 2015, an outbreak of typhoid fever started in the capital city of Uganda, and 1940 suspected cases were reported by 5 March 2015. In this report, we describe a case of typhoid fever caused by a MDR strain with HIV infection and hemoglobin S-syndrome thalassemia in an Ugandan from Kampala City. It is essential to consider MDR strains of Salmonella enterica serovar Typhi infections, including fluoroquinolone-resistant strains, in patients from Africa and Southeast Asia.


Internal Medicine | 2016

Progressive HIV-associated Cholangiopathy in an HIV Patient Treated with Combination Antiretroviral Therapy

Kazuo Imai; Kazuhisa Misawa; Takahiro Matsumura; Yuji Fujikura; Kei Mikita; Masaharu Tokoro; Takuya Maeda; Akihiko Kawana


Journal of Microbiological Methods | 2018

Corrigendum to “A novel detection procedure for mutations in the 23S rRNA gene of Mycoplasma pneumoniae with peptide nucleic acid-mediated loop-mediated isothermal amplification assay” [J. Microbiol. Methods 141 (2017) 90–96]

Jun Sakai; Takuya Maeda; Norihito Tarumoto; Kazuhisa Misawa; Shinsuke Tamura; Kazuo Imai; Toshiyuki Yamaguchi; Satoshi Iwata; Takashi Murakami; Shigefumi Maesaki


Open Forum Infectious Diseases | 2017

A novel diagnostic method for Malaria using loop mediated isothermal amplification (LAMP) and MinION nanopore sequencer

Kazuo Imai; Norihito Tarumoto; Kazuhisa Misawa; Jun Sakai; Kyoko Hayashida; Yuki Eshita; Ryuichiro Maeda; Josef Tuda; Takashi Murakami; Shigefumi Maesaki; Yutaka Suzuki; Junya Yamagishi; Takuya Maeda

Collaboration


Dive into the Kazuhisa Misawa's collaboration.

Top Co-Authors

Avatar

Kazuo Imai

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Takuya Maeda

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Akihiko Kawana

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Yuji Fujikura

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Shigefumi Maesaki

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Takashi Murakami

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Jun Sakai

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Kei Mikita

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Morichika Osa

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Norihito Tarumoto

Saitama Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge